A guide to the coronavirus vaccination rollout and what you need to know about the authorized vaccines
LAST UPDATED: JULY 27, 2021 4:11 PM EDT
How the U.S. Vaccine Rollout Looks Right Now
Percentage of U.S. Population Vaccinated To Date
Initial Dose: 179M (54.0%)
Complete: 163M (49.2%)
Total Population: 332M
Some seven months into the U.S. COVID-19 vaccine rollout, 49.2% of Americans have received both doses of the two-shot Pfizer-BioNTech and Moderna drugs or a single injection of the one-dose Johnson & Johnson/Janssen version. Including "initial doses"—those who have received only the first dose of Pfizer or Moderna—the figure stands at 54%. (Many sources include Johnson & Johnson in this figure as "at least one dose," while TIME counts it as a completed treatment.)
Click a state to compare historical figures to the U.S. as a whole
Percent Vaccinated in Each State
DE DC MA RI CT NH NJ VT
The U.S. has administered 179,295,066 initial doses (54.0%) and completed 163,312,474 vaccinations (49.2%)
Percent of Population Vaccinated
Note: On Feb. 22, the CDC changed its reporting method to refer to the patient's state of residence, not the state where the vaccine was administered, leading to some fluctuation in the rolling figures that month.
Status of the Supply
PCT. OF SHIPPED DOSES ADMINISTERED
CLICK A STATE TO SEE DETAILS
DE DC MA RI CT NH NJ VT
The U.S. has delivered 395,460,845 total doses, of which 342,607,540 (86.6%) have been administered
EACH BLOCK IS 1% (3,954,608) OF THE TOTAL DOSES SHIPPED
While a few smaller states say they have administered virtually all of the first doses they have received from the federal government, there remains a nationwide gap between the reported number of surplus doses and ground-level reports of mass shortages. While the Department of Health and Human Services releases weekly figures on vaccine allocations and shipments to every state, territory, and a handful of federal programs, these maps use Centers for Disease Control and Prevention figures to show how many of those doses have arrived on site each day.
The Coronavirus Brief.
Everything you need to know about the global spread of COVID-19
Answers to Key Questions About the COVID-19 Vaccine Rollout, and the Science Behind the Shots
To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver College of Medicine and a member of the U.S. Food and Drug Administration’s (FDA) vaccine advisory committee, and Angela Shen, a visiting scientist with the Vaccine Education Center at Children’s Hospital of Philadelphia.
Click on any of the questions below to see the answers.